Pink Sheet is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Dietary supplement enforcement

This article was originally published in The Tan Sheet

Executive Summary

Language added to Agriculture Appropriations bill by Sens. Orrin Hatch (R-Utah) and Tom Harkin (D-Iowa) Oct. 25 would provide CFSAN with $1 mil. to "enhance enforcement of requirements under [DSHEA] related to the accuracy of product labeling, and the truthfulness and substantiation of claims." HR 2330 passed the Senate 91-5 with 36 amendments the same day and now is headed for a conference between the two chambers. Introducing the amendment, Hatch noted he and Harkin have become "increasingly alarmed over reports that unsafe or mislabeled dietary supplement products are being marketed." Hatch also expressed concern about the number of teenagers taking performance-enhancing products, adding "it is not clear they fall within the legal definition of dietary supplement"

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

PS093205

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel